

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.90006859 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.90006859 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.90006859 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.90006859 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.90006859 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.90006859 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.80762264 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.46167871 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.33046823 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.32889258 |
| 11 | respiratory burst (GO:0045730) | 5.21045241 |
| 12 | detection of other organism (GO:0098543) | 5.09621839 |
| 13 | response to peptidoglycan (GO:0032494) | 5.08572356 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.01601568 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.98515186 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.85153667 |
| 17 | response to host immune response (GO:0052572) | 4.85153667 |
| 18 | microglial cell activation (GO:0001774) | 4.84784695 |
| 19 | detection of bacterium (GO:0016045) | 4.78829844 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.66823180 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66823180 |
| 22 | response to host defenses (GO:0052200) | 4.53691878 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.53691878 |
| 24 | response to host (GO:0075136) | 4.53691878 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.51115136 |
| 26 | macrophage activation (GO:0042116) | 4.23082584 |
| 27 | leukocyte aggregation (GO:0070486) | 4.23057998 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 4.22601042 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18311301 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 4.15169180 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 4.01910432 |
| 32 | neutrophil activation (GO:0042119) | 4.00506845 |
| 33 | mannose metabolic process (GO:0006013) | 3.99584205 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.99495608 |
| 35 | negative regulation of granulocyte differentiation (GO:0030853) | 3.99135316 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.98644377 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.97513582 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.94571999 |
| 39 | neutrophil mediated immunity (GO:0002446) | 3.93572925 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.92881577 |
| 41 | granulocyte activation (GO:0036230) | 3.91866868 |
| 42 | positive regulation of mast cell activation (GO:0033005) | 3.90170713 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.87802363 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.87016028 |
| 45 | apoptotic cell clearance (GO:0043277) | 3.78182275 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.77223736 |
| 47 | lipoxygenase pathway (GO:0019372) | 3.74837540 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.73231083 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.72522768 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.71192493 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.70499768 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.67724948 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.65416965 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.61681035 |
| 55 | leukotriene metabolic process (GO:0006691) | 3.59358431 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59244596 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.58515652 |
| 58 | superoxide anion generation (GO:0042554) | 3.56926832 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54287726 |
| 60 | regulation of integrin activation (GO:0033623) | 3.53595519 |
| 61 | response to fungus (GO:0009620) | 3.50907079 |
| 62 | germinal center formation (GO:0002467) | 3.50368217 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.49657022 |
| 64 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.48462020 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.48462020 |
| 66 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.46663291 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43882991 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41202784 |
| 69 | regulation of apoptotic cell clearance (GO:2000425) | 3.40961845 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 3.39894486 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39755774 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 3.35518080 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.33762533 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 3.29681544 |
| 75 | positive regulation of chemokine secretion (GO:0090197) | 3.29073489 |
| 76 | * neutrophil chemotaxis (GO:0030593) | 3.28727820 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.27325933 |
| 78 | pinocytosis (GO:0006907) | 3.26707737 |
| 79 | regulation of macrophage chemotaxis (GO:0010758) | 3.24687403 |
| 80 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21410258 |
| 81 | I-kappaB phosphorylation (GO:0007252) | 3.19475158 |
| 82 | * neutrophil migration (GO:1990266) | 3.18895159 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18777347 |
| 84 | regulation of phagocytosis (GO:0050764) | 3.17541053 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16830255 |
| 86 | leukocyte degranulation (GO:0043299) | 3.15324875 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14998765 |
| 88 | positive regulation of leukocyte degranulation (GO:0043302) | 3.12450530 |
| 89 | reactive oxygen species biosynthetic process (GO:1903409) | 3.09933623 |
| 90 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.09108152 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 3.04719117 |
| 92 | regulation of tolerance induction (GO:0002643) | 3.01683709 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01500690 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01147427 |
| 95 | myeloid leukocyte activation (GO:0002274) | 3.00255960 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97928818 |
| 97 | defense response to protozoan (GO:0042832) | 2.96169908 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 2.94341761 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 2.94276316 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.91932507 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90764356 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.90648642 |
| 103 | positive regulation of interferon-beta production (GO:0032728) | 2.89549521 |
| 104 | defense response to fungus (GO:0050832) | 2.89258695 |
| 105 | negative thymic T cell selection (GO:0045060) | 2.88451798 |
| 106 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87134429 |
| 107 | * cellular extravasation (GO:0045123) | 2.86138341 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85712975 |
| 109 | * leukocyte cell-cell adhesion (GO:0007159) | 2.85396420 |
| 110 | response to protozoan (GO:0001562) | 2.85050081 |
| 111 | regulation of B cell differentiation (GO:0045577) | 2.84338724 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83863895 |
| 113 | negative regulation of type 2 immune response (GO:0002829) | 2.83723924 |
| 114 | positive regulation of regulated secretory pathway (GO:1903307) | 2.82326420 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82196890 |
| 116 | * granulocyte chemotaxis (GO:0071621) | 2.81724333 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.81232043 |
| 118 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81026164 |
| 119 | B cell mediated immunity (GO:0019724) | 2.79618625 |
| 120 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79583329 |
| 121 | negative regulation of mast cell activation (GO:0033004) | 2.78680190 |
| 122 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.78056059 |
| 123 | phagosome maturation (GO:0090382) | 2.77747113 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.77270722 |
| 125 | response to interleukin-15 (GO:0070672) | 2.75964941 |
| 126 | cellular defense response (GO:0006968) | 2.75928110 |
| 127 | macrophage differentiation (GO:0030225) | 2.75583853 |
| 128 | * granulocyte migration (GO:0097530) | 2.75052797 |
| 129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72855569 |
| 130 | negative T cell selection (GO:0043383) | 2.72748931 |
| 131 | negative regulation of innate immune response (GO:0045824) | 2.72637565 |
| 132 | * leukocyte migration involved in inflammatory response (GO:0002523) | 2.72135513 |
| 133 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72087532 |
| 134 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71799543 |
| 135 | lymphocyte chemotaxis (GO:0048247) | 2.70683532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.53234292 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.52680480 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.82801841 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.65263874 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40157471 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90431422 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.84769593 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.68486538 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.65663014 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25458363 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.18572010 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06074972 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.04811640 |
| 14 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.73086286 |
| 15 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55919039 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52240138 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.48166994 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.47793630 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46456357 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44869734 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38932202 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20555629 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20446594 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18993857 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13687942 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08548455 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.06299297 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03295265 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99806664 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97946122 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97725800 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90110994 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81652305 |
| 34 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.80706378 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79880682 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78105531 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74550756 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.72776611 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67826777 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65144493 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.64094698 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63151314 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60516741 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59570962 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59221984 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53215955 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52986181 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49248779 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47214976 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.42102805 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40078758 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33960110 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33407450 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30892865 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.30315855 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28495238 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27407691 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26666753 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25753844 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24164641 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23465954 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17436593 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16366909 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14730019 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14415141 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13298292 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12755290 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12142326 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10117800 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09312279 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06626825 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06292303 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05812709 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03983293 |
| 75 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.03856318 |
| 76 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02788137 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02108747 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99985445 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99659471 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98032936 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97508863 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97445161 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95738650 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95330076 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95116610 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94849801 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91469981 |
| 88 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.91416790 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89276971 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86814045 |
| 91 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86139938 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86130484 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85586009 |
| 94 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85233139 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 0.85174642 |
| 96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82546441 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82020326 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78270453 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77083840 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76213734 |
| 101 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.75263197 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68596035 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68482171 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.66765735 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66495325 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62628109 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.62582406 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.61644217 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.61110541 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.61013646 |
| 111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60702472 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57611678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.41050649 |
| 2 | MP0003436_decreased_susceptibility_to | 4.20371568 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.14753732 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.57766674 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.40969342 |
| 6 | MP0006082_CNS_inflammation | 3.08442224 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.00720502 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.84922263 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.77551105 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.72440702 |
| 11 | * MP0005025_abnormal_response_to | 2.70611145 |
| 12 | MP0001790_abnormal_immune_system | 2.61042681 |
| 13 | MP0005387_immune_system_phenotype | 2.61042681 |
| 14 | MP0009785_altered_susceptibility_to | 2.59184718 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.54022944 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.53099254 |
| 17 | MP0003724_increased_susceptibility_to | 2.50550348 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.43016705 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.41305445 |
| 20 | MP0001800_abnormal_humoral_immune | 2.41002274 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.32228651 |
| 22 | MP0000685_abnormal_immune_system | 2.28816912 |
| 23 | MP0002723_abnormal_immune_serum | 2.24579632 |
| 24 | * MP0001819_abnormal_immune_cell | 2.16108504 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 2.15435042 |
| 26 | MP0009278_abnormal_bone_marrow | 2.14336889 |
| 27 | MP0005671_abnormal_response_to | 2.11592554 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.04408551 |
| 29 | MP0004510_myositis | 1.96956695 |
| 30 | MP0001851_eye_inflammation | 1.95390131 |
| 31 | MP0002405_respiratory_system_inflammati | 1.95363249 |
| 32 | MP0009840_abnormal_foam_cell | 1.90884260 |
| 33 | MP0000343_altered_response_to | 1.90220952 |
| 34 | MP0004947_skin_inflammation | 1.87512446 |
| 35 | * MP0001845_abnormal_inflammatory_respons | 1.79481422 |
| 36 | MP0003690_abnormal_glial_cell | 1.77614244 |
| 37 | MP0005451_abnormal_body_composition | 1.75587521 |
| 38 | * MP0003075_altered_response_to | 1.62448897 |
| 39 | MP0001853_heart_inflammation | 1.60187985 |
| 40 | MP0003448_altered_tumor_morphology | 1.57650711 |
| 41 | * MP0000716_abnormal_immune_system | 1.57472192 |
| 42 | MP0000604_amyloidosis | 1.54686881 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.53810319 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.52243145 |
| 45 | MP0008469_abnormal_protein_level | 1.49558261 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.47451447 |
| 47 | MP0005310_abnormal_salivary_gland | 1.45878638 |
| 48 | * MP0002398_abnormal_bone_marrow | 1.43718258 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.41609720 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.40252016 |
| 51 | MP0002933_joint_inflammation | 1.35955725 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.33939514 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.33939514 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.33901776 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.32112634 |
| 56 | MP0008004_abnormal_stomach_pH | 1.31081264 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.29324848 |
| 58 | MP0002132_abnormal_respiratory_system | 1.29236157 |
| 59 | * MP0002429_abnormal_blood_cell | 1.27882067 |
| 60 | MP0002722_abnormal_immune_system | 1.23816791 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.23587741 |
| 62 | MP0003828_pulmonary_edema | 1.22120568 |
| 63 | MP0005390_skeleton_phenotype | 1.20836525 |
| 64 | MP0000858_altered_metastatic_potential | 1.15354094 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.14070964 |
| 66 | MP0003866_abnormal_defecation | 1.09829197 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.07560556 |
| 68 | MP0010307_abnormal_tumor_latency | 1.05761275 |
| 69 | MP0002006_tumorigenesis | 1.05753140 |
| 70 | MP0009764_decreased_sensitivity_to | 1.04934028 |
| 71 | * MP0005166_decreased_susceptibility_to | 1.03659030 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.00004847 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.95737355 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.95175340 |
| 75 | MP0000249_abnormal_blood_vessel | 0.93791649 |
| 76 | MP0005023_abnormal_wound_healing | 0.93432090 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.92727526 |
| 78 | MP0004883_abnormal_blood_vessel | 0.92590199 |
| 79 | MP0004381_abnormal_hair_follicle | 0.92231287 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.90070502 |
| 81 | MP0009763_increased_sensitivity_to | 0.87737369 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 0.86685606 |
| 83 | MP0005164_abnormal_response_to | 0.83837912 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.82428317 |
| 85 | MP0003329_amyloid_beta_deposits | 0.81667175 |
| 86 | MP0001873_stomach_inflammation | 0.81211540 |
| 87 | MP0000490_abnormal_crypts_of | 0.80815031 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.80206028 |
| 89 | * MP0003566_abnormal_cell_adhesion | 0.79433852 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.77064795 |
| 91 | MP0000920_abnormal_myelination | 0.76521828 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.76015323 |
| 93 | MP0003795_abnormal_bone_structure | 0.74716866 |
| 94 | MP0003045_fibrosis | 0.72573543 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.69150614 |
| 96 | MP0008874_decreased_physiological_sensi | 0.68052489 |
| 97 | MP0001915_intracranial_hemorrhage | 0.67972471 |
| 98 | MP0003091_abnormal_cell_migration | 0.66819144 |
| 99 | MP0000371_diluted_coat_color | 0.66496588 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.66024322 |
| 101 | MP0001663_abnormal_digestive_system | 0.63967415 |
| 102 | MP0004130_abnormal_muscle_cell | 0.63955328 |
| 103 | MP0002928_abnormal_bile_duct | 0.62675400 |
| 104 | MP0008260_abnormal_autophagy | 0.60951319 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.60453606 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.59832478 |
| 107 | MP0003279_aneurysm | 0.59489411 |
| 108 | MP0009115_abnormal_fat_cell | 0.58300986 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.56466739 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.55518575 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.53578302 |
| 112 | MP0008873_increased_physiological_sensi | 0.52929671 |
| 113 | MP0005388_respiratory_system_phenotype | 0.52918161 |
| 114 | MP0002133_abnormal_respiratory_system | 0.52918161 |
| 115 | MP0001958_emphysema | 0.51977792 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.49661720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.64782686 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.09763121 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.71199038 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.62867771 |
| 5 | * Systemic lupus erythematosus (HP:0002725) | 6.00641227 |
| 6 | Glomerulonephritis (HP:0000099) | 5.51030565 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.99722936 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.96541752 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.81237370 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.63188062 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.25213615 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.25213615 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.25213615 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.18916848 |
| 15 | Gingivitis (HP:0000230) | 4.11739476 |
| 16 | Obstructive lung disease (HP:0006536) | 4.06963496 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06963496 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.98961929 |
| 19 | Recurrent skin infections (HP:0001581) | 3.93964010 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.72705006 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.72705006 |
| 22 | Abnormality of complement system (HP:0005339) | 3.72545556 |
| 23 | Complement deficiency (HP:0004431) | 3.67231052 |
| 24 | Disinhibition (HP:0000734) | 3.60108629 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.59258252 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.56233063 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.56233063 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.56233063 |
| 29 | Myositis (HP:0100614) | 3.40556511 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.31271183 |
| 31 | Nephritis (HP:0000123) | 3.23828319 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19997644 |
| 33 | Cellulitis (HP:0100658) | 3.19042008 |
| 34 | Axonal loss (HP:0003447) | 3.16255163 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.09836681 |
| 36 | Pustule (HP:0200039) | 3.09791490 |
| 37 | Encephalitis (HP:0002383) | 3.05520501 |
| 38 | Periodontitis (HP:0000704) | 3.05446742 |
| 39 | Amyloidosis (HP:0011034) | 3.02691026 |
| 40 | Orchitis (HP:0100796) | 2.96304385 |
| 41 | Loss of speech (HP:0002371) | 2.87658324 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.83825801 |
| 43 | Hemoptysis (HP:0002105) | 2.83648024 |
| 44 | Stomatitis (HP:0010280) | 2.80644411 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.80642197 |
| 46 | T lymphocytopenia (HP:0005403) | 2.78307104 |
| 47 | Increased IgE level (HP:0003212) | 2.74832874 |
| 48 | Prostate neoplasm (HP:0100787) | 2.72688478 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.71785106 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67605566 |
| 51 | Urticaria (HP:0001025) | 2.66130662 |
| 52 | Agnosia (HP:0010524) | 2.65387552 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.63712637 |
| 54 | Thoracic kyphosis (HP:0002942) | 2.62865934 |
| 55 | Hematochezia (HP:0002573) | 2.61514746 |
| 56 | Chest pain (HP:0100749) | 2.60926107 |
| 57 | Recurrent viral infections (HP:0004429) | 2.60229005 |
| 58 | Spondylolisthesis (HP:0003302) | 2.59944865 |
| 59 | Purpura (HP:0000979) | 2.55115017 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.52764426 |
| 61 | Meningitis (HP:0001287) | 2.51753000 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.50436827 |
| 63 | Optic neuritis (HP:0100653) | 2.50436827 |
| 64 | Abnormality of the lumbar spine (HP:0100712) | 2.48067449 |
| 65 | Mutism (HP:0002300) | 2.48047855 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.44766121 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44543160 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44543160 |
| 69 | Episodic fever (HP:0001954) | 2.43909848 |
| 70 | Arterial tortuosity (HP:0005116) | 2.39682271 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.39204125 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.38229808 |
| 73 | Osteomyelitis (HP:0002754) | 2.33141110 |
| 74 | Increased serum ferritin (HP:0003281) | 2.32747072 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.31216074 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31158384 |
| 77 | Myocardial infarction (HP:0001658) | 2.29422430 |
| 78 | Pulmonary embolism (HP:0002204) | 2.29419211 |
| 79 | Anorexia (HP:0002039) | 2.28935085 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.27846842 |
| 81 | Arterial thrombosis (HP:0004420) | 2.26012759 |
| 82 | Leukocytosis (HP:0001974) | 2.25739222 |
| 83 | Pathologic fracture (HP:0002756) | 2.22487566 |
| 84 | Thick nail (HP:0001805) | 2.22330915 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.19850865 |
| 86 | Vasculitis (HP:0002633) | 2.18557273 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.16628986 |
| 88 | Colitis (HP:0002583) | 2.16076518 |
| 89 | Asymmetric septal hypertrophy (HP:0001670) | 2.15903941 |
| 90 | Inflammation of the large intestine (HP:0002037) | 2.15311534 |
| 91 | Increased IgM level (HP:0003496) | 2.13439720 |
| 92 | Granulocytopenia (HP:0001913) | 2.11766514 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 2.11542903 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11542903 |
| 95 | Abnormality of T cells (HP:0002843) | 2.10739428 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.10724715 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.06569496 |
| 98 | Deformed sella turcica (HP:0002681) | 2.06011248 |
| 99 | Petechiae (HP:0000967) | 2.05066752 |
| 100 | Vascular tortuosity (HP:0004948) | 2.03297498 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.03247699 |
| 102 | Abnormality of the thoracic spine (HP:0100711) | 2.02667203 |
| 103 | Gangrene (HP:0100758) | 2.02332729 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.01149953 |
| 105 | Chronic otitis media (HP:0000389) | 1.98960084 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.98740340 |
| 107 | Vertigo (HP:0002321) | 1.98323907 |
| 108 | Gastrointestinal inflammation (HP:0004386) | 1.97428815 |
| 109 | Hypochromic anemia (HP:0001931) | 1.97344136 |
| 110 | Peritonitis (HP:0002586) | 1.96720702 |
| 111 | Polyneuropathy (HP:0001271) | 1.96620824 |
| 112 | IgM deficiency (HP:0002850) | 1.95871767 |
| 113 | Abnormality of the pleura (HP:0002103) | 1.95550977 |
| 114 | Apathy (HP:0000741) | 1.94257984 |
| 115 | Abnormality of the endocardium (HP:0004306) | 1.93685813 |
| 116 | Diminished motivation (HP:0000745) | 1.92246041 |
| 117 | Amaurosis fugax (HP:0100576) | 1.91964619 |
| 118 | Inappropriate behavior (HP:0000719) | 1.91958461 |
| 119 | Epistaxis (HP:0000421) | 1.91804330 |
| 120 | Thickened calvaria (HP:0002684) | 1.91502300 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.91391800 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.91189913 |
| 123 | Gingival bleeding (HP:0000225) | 1.91055888 |
| 124 | Cheilitis (HP:0100825) | 1.88877754 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.88666879 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.88504089 |
| 127 | Slow saccadic eye movements (HP:0000514) | 1.87085111 |
| 128 | Sepsis (HP:0100806) | 1.86638657 |
| 129 | Menorrhagia (HP:0000132) | 1.86570276 |
| 130 | Glomerulopathy (HP:0100820) | 1.86553510 |
| 131 | Increased CSF protein (HP:0002922) | 1.84813929 |
| 132 | Progressive visual loss (HP:0000529) | 1.83598955 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 1.83571002 |
| 134 | Progressive neurologic deterioration (HP:0002344) | 1.83413296 |
| 135 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83095261 |
| 136 | Joint hemorrhage (HP:0005261) | 1.82167284 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81481170 |
| 138 | Retinal atrophy (HP:0001105) | 1.81012438 |
| 139 | Absent frontal sinuses (HP:0002688) | 1.78548505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.51288669 |
| 2 | RIPK4 | 3.91555398 |
| 3 | IRAK4 | 3.68994455 |
| 4 | TGFBR2 | 3.44784793 |
| 5 | MAP4K1 | 2.93197320 |
| 6 | PRPF4B | 2.76320930 |
| 7 | TYK2 | 2.61015260 |
| 8 | CSF1R | 2.44344970 |
| 9 | CAMK1D | 2.39092510 |
| 10 | ERN1 | 2.36387024 |
| 11 | FES | 2.29301838 |
| 12 | EPHB1 | 2.15034726 |
| 13 | TBK1 | 2.15022206 |
| 14 | KIT | 2.12304811 |
| 15 | STK10 | 1.96677516 |
| 16 | GRK7 | 1.95772439 |
| 17 | FGR | 1.93320818 |
| 18 | CSK | 1.90984228 |
| 19 | TAOK3 | 1.87591724 |
| 20 | CAMK1G | 1.86925283 |
| 21 | MAP3K14 | 1.80815912 |
| 22 | HCK | 1.79910023 |
| 23 | IRAK3 | 1.71008166 |
| 24 | ZAP70 | 1.69209175 |
| 25 | TAOK1 | 1.65052667 |
| 26 | TXK | 1.58386015 |
| 27 | SIK2 | 1.56836625 |
| 28 | MST1R | 1.55902527 |
| 29 | BTK | 1.54195899 |
| 30 | MAP2K3 | 1.52518043 |
| 31 | TRIB3 | 1.51829496 |
| 32 | JAK1 | 1.44266403 |
| 33 | RIPK1 | 1.42479315 |
| 34 | TTN | 1.41929009 |
| 35 | CLK1 | 1.38138066 |
| 36 | SYK | 1.33384930 |
| 37 | PKN2 | 1.32058387 |
| 38 | MAP3K13 | 1.31168331 |
| 39 | MARK3 | 1.27819318 |
| 40 | LYN | 1.26665687 |
| 41 | KSR2 | 1.22473617 |
| 42 | LCK | 1.21021596 |
| 43 | IKBKB | 1.17812259 |
| 44 | PAK4 | 1.15146364 |
| 45 | TEC | 1.15068731 |
| 46 | MATK | 1.11384216 |
| 47 | IKBKE | 1.07989374 |
| 48 | TAOK2 | 1.07395569 |
| 49 | GRK6 | 1.04681568 |
| 50 | TRPM7 | 1.03776755 |
| 51 | JAK3 | 1.00023012 |
| 52 | PTK6 | 0.98931856 |
| 53 | BMPR2 | 0.97882164 |
| 54 | ITK | 0.97734645 |
| 55 | JAK2 | 0.94981974 |
| 56 | BMX | 0.92803875 |
| 57 | CAMKK2 | 0.92228982 |
| 58 | IRAK2 | 0.91161708 |
| 59 | CDC42BPA | 0.90715571 |
| 60 | IRAK1 | 0.89076436 |
| 61 | MARK2 | 0.88682486 |
| 62 | LRRK2 | 0.81449121 |
| 63 | RPS6KA4 | 0.81049559 |
| 64 | NEK9 | 0.80803515 |
| 65 | MAPK7 | 0.76850007 |
| 66 | CAMKK1 | 0.76014274 |
| 67 | EGFR | 0.75017592 |
| 68 | MAP3K5 | 0.74181668 |
| 69 | MAP3K2 | 0.70954340 |
| 70 | MAP3K11 | 0.68403378 |
| 71 | MAPKAPK2 | 0.60431452 |
| 72 | PIM1 | 0.59948392 |
| 73 | FYN | 0.59860761 |
| 74 | SIK3 | 0.58669355 |
| 75 | PRKD2 | 0.58332028 |
| 76 | PRKCH | 0.57145241 |
| 77 | MAP2K4 | 0.57143115 |
| 78 | MAP3K3 | 0.57006548 |
| 79 | ADRBK2 | 0.56738959 |
| 80 | FGFR3 | 0.55440194 |
| 81 | SCYL2 | 0.55313983 |
| 82 | PRKCD | 0.54991328 |
| 83 | YES1 | 0.52982484 |
| 84 | PRKCQ | 0.51951062 |
| 85 | DAPK2 | 0.48945212 |
| 86 | RET | 0.48391344 |
| 87 | SGK2 | 0.47798299 |
| 88 | IGF1R | 0.47716874 |
| 89 | RPS6KA6 | 0.47647565 |
| 90 | EPHA3 | 0.47291269 |
| 91 | ABL1 | 0.46695642 |
| 92 | MAPK15 | 0.46550907 |
| 93 | PDPK1 | 0.46484390 |
| 94 | PDK1 | 0.45654273 |
| 95 | MOS | 0.44350238 |
| 96 | RPS6KC1 | 0.44272057 |
| 97 | RPS6KL1 | 0.44272057 |
| 98 | MAP2K6 | 0.43913109 |
| 99 | RPS6KA2 | 0.43686441 |
| 100 | KSR1 | 0.43469559 |
| 101 | STK4 | 0.42609016 |
| 102 | CDK12 | 0.42154561 |
| 103 | CDK6 | 0.42152129 |
| 104 | CHUK | 0.41087869 |
| 105 | PIM2 | 0.40986544 |
| 106 | HIPK2 | 0.40195999 |
| 107 | DMPK | 0.40170288 |
| 108 | ALK | 0.39600141 |
| 109 | STK11 | 0.39344192 |
| 110 | MAP3K7 | 0.39222584 |
| 111 | RAF1 | 0.39158321 |
| 112 | MAP3K9 | 0.39074254 |
| 113 | MAPK4 | 0.35427917 |
| 114 | DYRK1B | 0.35155873 |
| 115 | MAP3K6 | 0.34868882 |
| 116 | PIK3CG | 0.31520402 |
| 117 | TESK2 | 0.29829656 |
| 118 | SGK3 | 0.29003371 |
| 119 | CAMK4 | 0.28855537 |
| 120 | MAPK12 | 0.27088975 |
| 121 | SRC | 0.25485843 |
| 122 | PTK2B | 0.23348051 |
| 123 | MAP3K1 | 0.22832748 |
| 124 | TNK2 | 0.22446779 |
| 125 | MAP3K8 | 0.20339540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.67015840 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.56470922 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.52807636 |
| 4 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.04610611 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.75416086 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71505008 |
| 7 | * Pertussis_Homo sapiens_hsa05133 | 2.45871944 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18502593 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.08558990 |
| 10 | * Tuberculosis_Homo sapiens_hsa05152 | 2.06391027 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99466077 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.98936086 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.87447885 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.78767318 |
| 15 | * Phagosome_Homo sapiens_hsa04145 | 1.76749894 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.73616990 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57748564 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56575815 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55854331 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54972869 |
| 21 | * Legionellosis_Homo sapiens_hsa05134 | 1.53440448 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.51153432 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49053651 |
| 24 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48006844 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45270553 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42449252 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41552000 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.39434362 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38672798 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38545631 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37218209 |
| 32 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36286825 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.34854170 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33660342 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28029773 |
| 36 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24977355 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.24254006 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.15375305 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14867127 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14501944 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10606195 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10276040 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09188703 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.05066723 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.04838694 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.02321975 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00678630 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00677224 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99493426 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.98939554 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95930091 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95096276 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93739094 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88807066 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86464049 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85135653 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85130295 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84204334 |
| 59 | * Amoebiasis_Homo sapiens_hsa05146 | 0.84122665 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82872433 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81654751 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.80442501 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.71956708 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71081428 |
| 65 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70723640 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67836484 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65459949 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64402141 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63620047 |
| 70 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60912765 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60524834 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59335877 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.58947283 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57492109 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57465539 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55811645 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54410417 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51310365 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51225959 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49937434 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49536190 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49149520 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48622939 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47889565 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47335564 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47277650 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47142525 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45960563 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43356876 |
| 90 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42070217 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40887680 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40260066 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39950091 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.39595029 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38208189 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.38129869 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.37099971 |
| 98 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36415598 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35996538 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35794192 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34106974 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33085128 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32971472 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31972274 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.31841055 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31284538 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.27712908 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.27697203 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26425806 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25778951 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24907522 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23320360 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23283140 |

